Extended Data Table 1 ∣.
Pathology outcomes post-treatment
Overall (N=32) |
|
---|---|
Gleason grade group at prostatectomy | |
2 | 8 (25.0%) |
3 | 9 (28.1%) |
4 | 0 (0%) |
5 | 15 (46.9%) |
Gleason sum at prostatectomy | |
7 | 17 (53.1%) |
8 | 0 (0%) |
9-10 | 15 (46.9%) |
Pathological (surgical) stage | |
Yes | 32 (100%) |
Presence of lymphovascular invasion | |
Yes | 2 (6.3%) |
No | 30 (93.8%) |
Presence of extraprostatic extension | |
Yes | 19 (59.4%) |
No | 13 (40.6%) |
Presence of seminal vesicle invasion | |
Yes | 8 (25.0%) |
No | 24 (75.0%) |
Positive margins | |
Yes | 10 (31.3%) |
No | 22 (68.8%) |
Positive lymph nodes | |
Yes | 4 (12.5%) |
No | 28 (87.5%) |
Pathologic Complete Response (pCR) | |
Yes | 0 (0%) |
No | 32 (100%) |
CAPRA-S score | |
0-2 | 4 (12.5%) |
3-5 | 12 (37.5%) |
6 + | 16 (50.0%) |